Pathogen Structure as an Immune Target
The logic of the antifungal response is fundamentally based on the structure of the pathogen. Fungi differ significantly from bacteria by possessing a thick, complex, multilayered cell wall.
This structure serves as the primary target for recognition by host defense systems. The cell wall consists of:
- Polysaccharides: mannans, glucans, cellulose, and chitin (the main structural scaffold).
- Proteins and lipids embedded in the polysaccharide matrix.
Innate Immunity: The First Line of Defense
Innate immunity bears the initial brunt of contact with fungal agents. Defense at this stage is carried out through three main mechanisms:
- Barrier factors. The physical integrity of the skin and mucous membranes prevents invasion. Additionally, sebaceous and sweat gland secretions contain natural antimicrobial peptides that are detrimental to micromycetes.
- Competitive defense. Healthy normal microflora acts as a powerful antagonist. Bacteria compete with fungi for nutrients and ecological niches, strictly suppressing their overgrowth.
- Receptor recognition. If a fungus breaches these barriers, innate immune cells come into play. They use specialized receptors (primarily TLR2, TLR4, and dectin-1) to recognize fungal cell wall polysaccharides and trigger an inflammatory cascade.
Adaptive Immunity and Tissue Responses
If innate mechanisms fail, adaptive immunity is activated. In mycoses, T-cell immunity plays a leading role. The humoral response (production of IgM and IgG antibodies) is of secondary importance and cannot independently ensure complete clearance of fungi from the organism.
A characteristic pathomorphological pattern unfolds at the site of inflammation:
- Phagocytosis is sharply enhanced and activated.
- Specific epithelioid granulomas form, limiting the spread of the pathogen.
- Thrombosis frequently develops in blood vessels adjacent to the inflammation site, which impairs tissue trophism but isolates the pathogen.
Clinical and Immunological Features of Mycoses
Fungal infections (especially opportunistic ones) rarely affect completely healthy individuals. They manifest against a background of immunodeficiencies or following prolonged antibiotic therapy when the protective normal microflora has been depleted.
The infectious process is always accompanied by the development of delayed-type hypersensitivity (DTH). However, fungi can also trigger allergic reactions (immediate-type hypersensitivity — ITH).
Respiratory sensitization most commonly occurs upon inhaling microscopic fragments of fungi of the genera Aspergillus, Penicillium, Mucor, or Fusarium. The body begins to synthesize specific IgE antibodies, leading to severe allergic conditions (e.g., bronchial asthma).
In clinical practice, specific skin tests with fungal antigens are widely used to diagnose active infection (DTH) or allergy (ITH).